Antiviral Activity of Fritillaria thunbergii Extract against Human Influenza Virus H1N1 (PR8) In Vitro, In Ovo and In Vivo
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Influenza viruses cause respiratory diseases in humans and animals with high morbidity and mortality rates. Conventional anti-influenza drugs are reported to exert side effects and newly emerging viral strains tend to develop resistance to these commonly used agents. Fritillaria thunbergii (FT) is traditionally used as an expectorant for controlling airway inflammatory disorders. Here, we evaluated the therapeutic effects of FT extracts against influenza virus type A (H1N1) infection in vitro, in ovo, and in vivo. In the post-treatment assay, FT extracts showed high CC50 (7,500 μg/ml), indicating low toxicity, and exerted moderate antiviral effects compared to oseltamivir (SI 50.6 vs. 222) in vitro. Antiviral activity tests in ovo revealed strong inhibitory effects of both FT extract and oseltamivir against H1N1 replication in embryonated eggs. Notably, at a treatment concentration of 150 mg/kg, only half the group administered oseltamivir survived whereas the FT group showed 100% survival, clearly demonstrating the low toxicity of FT extracts. Consistent with these findings, FT-administered mice showed a higher survival rate with lower body weight reduction relative to the oseltamivir group upon treatment 24 h after viral infection. Our collective results suggest that FT extracts exert antiviral effects against influenza H1N1 virus without inducing toxicity in vitro, in ovo or in vivo, thereby supporting the potential utility of FT extract as a novel candidate therapeutic drug or supplement against influenza.
Abstract
Influenza viruses cause respiratory diseases in humans and animals with high morbidity and mortality rates. Conventional anti-influenza drugs are reported to exert side effects and newly emerging viral strains tend to develop resistance to these commonly used agents. Fritillaria thunbergii (FT) is traditionally used as an expectorant for controlling airway inflammatory disorders. Here, we evaluated the therapeutic effects of FT extracts against influenza virus type A (H1N1) infection in vitro, in ovo, and in vivo. In the post-treatment assay, FT extracts showed high CC50 (7,500 μg/ml), indicating low toxicity, and exerted moderate antiviral effects compared to oseltamivir (SI 50.6 vs. 222) in vitro. Antiviral activity tests in ovo revealed strong inhibitory effects of both FT extract and oseltamivir against H1N1 replication in embryonated eggs. Notably, at a treatment concentration of 150 mg/kg, only half the group administered oseltamivir survived whereas the FT group showed 100% survival, clearly demonstrating the low toxicity of FT extracts. Consistent with these findings, FT-administered mice showed a higher survival rate with lower body weight reduction relative to the oseltamivir group upon treatment 24 h after viral infection. Our collective results suggest that FT extracts exert antiviral effects against influenza H1N1 virus without inducing toxicity in vitro, in ovo or in vivo, thereby supporting the potential utility of FT extract as a novel candidate therapeutic drug or supplement against influenza.
참고문헌 (14)
- Moscona A, "Neuraminidase inhibitors for influenza", N. England J. Med, 353, pp.1363~1373 (2005)
- Liu M, "Antigenic patterns and evolution of the human influenza A(H1N1)virus", Sci. Rep, 5, pp.14171~ (2015)
- Rewar S, "Treatment and prevention of pandemic H1N1 Influenza", Ann. Glob. Health, 81, pp.645~653 (2015)
- Gamblin SJ, "Influenza hemagglutinin and neuraminidase membrane glycoproteins", J. Biol. Chem, 285, pp.28403~28409 (2010)
- Chapple KJ, "Zanamivir in the treatment and prevention of influenza", Ann. Pharmacother., 34, pp.798~801 (2000)
- Du QS, "Designing inhibitors of M2 proton channel against H1N1 swine influenza virus", PLoS One, 5, pp.e9388~ (2010)
- Alvarado-Facundo E, "Influenza virus M2protein ion channel activity helps to maintain pandemic 2009 H1N1 virus hemagglutinin fusion competence during transport to the cell surface", J. Virol, 89, pp.1975~1985 (2015)
- He W, "Anti-influenza virus effect of aqueous extracts from dandelion", Virol. J, 8, pp.538~ (2011)
- 전상원, "Psychiatric Symptoms in a Patient with Influenza A (H1N1) Treated with Oseltamivir (Tamiflu): A Case Report", Clinical Psychopharmacology and Neuroscience, 13(2), pp.209~211 (2015), 대한정신약물학회
- Morimoto K, "Analysis of a child who developed abnormal neuropsychiatric symptoms after administration of oseltamivir : a case report", BMC Neurol, 15, pp.130~ (2015)
- Kim EJ, "Verticine, ebeiedine and suchengbeisine isolated from the bulbs of Fritillaria thunbergii Miq. inhibited the gene expression and production of MUC5AC mucin from human airway epithelial cells", Phytomedicine, 23, pp.95~104 (2016)
- Wang D, "Antitussive, expectorant and anti-inflammatory alkaloids from Bulbus Fritillariae Cirrhosae", Fitoterapia, 82, pp.1290~1294 (2011)
- Ozcelik B, "Antiviral and antimicrobial activities of three sesquiterpene lactones from Centaurea solstitialis L. ssp. solstitialis", Microbiol. Res., 164, pp.545~552 (2009)
- Hurt AC, "Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1)influenza viruses", Influenza Other Respir. Viruses, 3, pp.171~176 (2009)